Publication Results

Generate Report

Add publications by marking their checkboxes, or

Deciding on breast cancer risk reduction: The role of counseling in individual decision-making - A qualitative study.

Blakeslee SB,  McCaskill-Stevens W,  Parker PA,  Gunn CM,  Bandos H,  Bevers TB,  Battaglia TA,  Fagerlin A,  Müller-Nordhorn J,  Holmberg C
Patient Educ Couns 2017 Dec;100(12):2346-2354
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 28734560
PMC ID: PMC5683919

Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN,  Adams-Campbell LL,  Brawley OW,  Bickell N,  Carethers JM,  Flowers CR,  Foti M,  Gomez SL,  Griggs JJ,  Lathan CS,  Li CI,  Lichtenfeld JL,  McCaskill-Stevens W,  Paskett ED
J Clin Oncol 2017 Sep 10;35(26):3075-3082
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 28737975
PMC ID: not available

Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN,  Adams-Campbell LL,  Brawley OW,  Bickell N,  Carethers JM,  Flowers CR,  Foti M,  Gomez SL,  Griggs JJ,  Lathan CS,  Li CI,  Lichtenfeld JL,  McCaskill-Stevens W,  Paskett ED
Cancer Res 2017 Sep 1;77(17):4548-4555
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 28739629
PMC ID: not available

Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN,  Adams-Campbell LL,  Brawley OW,  Bickell N,  Carethers JM,  Flowers CR,  Foti M,  Gomez SL,  Griggs JJ,  Lathan CS,  Li CI,  Lichtenfeld JL,  McCaskill-Stevens W,  Paskett ED
CA Cancer J Clin 2017 Sep;67(5):353-361
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 28738442
PMC ID: not available

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.

Basch E,  Dueck AC,  Rogak LJ,  Minasian LM,  Kelly WK,  O'Mara AM,  Denicoff AM,  Seisler D,  Atherton PJ,  Paskett E,  Carey L,  Dickler M,  Heist RS,  Himelstein A,  Rugo HS,  Sikov WM,  Socinski MA,  Venook AP,  Weckstein DJ,  Lake DE,  Biggs DD,  Freedman RA,  Kuzma C,  Kirshner JJ,  Schrag D
JAMA Oncol 2017 Aug 1;3(8):1043-1050
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director ;  Supportive Care and Symptom Management
PubMed ID: 28208174
PMC ID: PMC5553624

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.

Basch E,  Pugh SL,  Dueck AC,  Mitchell SA,  Berk L,  Fogh S,  Rogak LJ,  Gatewood M,  Reeve BB,  Mendoza TR,  O'Mara AM,  Denicoff AM,  Minasian LM,  Bennett AV,  Setser A,  Schrag D,  Roof K,  Moore JK,  Gergel T,  Stephans K,  Rimner A,  DeNittis A,  Bruner DW
Int J Radiat Oncol Biol Phys 2017 Jun 1;98(2):409-418
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director ;  Supportive Care and Symptom Management
PubMed ID: 28463161
PMC ID: PMC5557037

Feasibility of a Centralized Clinical Trials Coverage Analysis: A Joint Initiative of the American Society of Clinical Oncology and the National Cancer Institute.

Szczepanek CM,  Hurley P,  Good MJ,  Denicoff A,  Willenberg K,  Dawson C,  Kurbegov D
J Oncol Pract 2017 Jun;13(6):395-400
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 28481681
PMC ID: not available

Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think Tank.

McCaskill-Stevens W,  Pearson DC,  Kramer BS,  Ford LG,  Lippman SM
Cancer Prev Res (Phila) 2017 Feb;10(2):99-107
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director
PubMed ID: 27965286
PMC ID: PMC5292088

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.

Himelstein AL,  Foster JC,  Khatcheressian JL,  Roberts JD,  Seisler DK,  Novotny PJ,  Qin R,  Go RS,  Grubbs SS,  O'Connor T,  Velasco MR Jr,  Weckstein D,  O'Mara A,  Loprinzi CL,  Shapiro CL
JAMA 2017 Jan 3;317(1):48-58
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 28030702
PMC ID: PMC5321662

Caring for caregivers and patients: Research and clinical priorities for informal cancer caregiving.

Kent EE,  Rowland JH,  Northouse L,  Litzelman K,  Chou WY,  Shelburne N,  Timura C,  O'Mara A,  Huss K
Cancer 2016 Jul 1;122(13):1987-95
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26991807
PMC ID: PMC5597246

Assessing Clinical Trial-Associated Workload in Community-Based Research Programs Using the ASCO Clinical Trial Workload Assessment Tool.

Good MJ,  Hurley P,  Woo KM,  Szczepanek C,  Stewart T,  Robert N,  Lyss A,  Gönen M,  Lilenbaum R
J Oncol Pract 2016 May;12(5):e536-47
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 27006354
PMC ID: PMC5702801

National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.

Majithia N,  Temkin SM,  Ruddy KJ,  Beutler AS,  Hershman DL,  Loprinzi CL
Support Care Cancer 2016 Mar;24(3):1439-47
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsSupportive Care and Symptom Management
PubMed ID: 26686859
PMC ID: PMC5078987

Results from NRG oncology/NSABP protocol DMP-1: Women's decision-making in breast cancer risk reduction

Holmberg C,  Bandos H,  Fagerlin A,  Bevers T B,  Battaglia T A,  Wickerham D L,  McCaskill-Stevens W
Cancer Res 2016 Feb 15;76(Suppl 4)
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: not available
PMC ID: not available

Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community.

Dimond EP,  Zon RT,  Weiner BJ,  St Germain D,  Denicoff AM,  Dempsey K,  Carrigan AC,  Teal RW,  Good MJ,  McCaskill-Stevens W,  Grubbs SS,  Dimond EP,  Zon RT,  Weiner BJ,  St Germain D,  Denicoff AM,  Dempsey K,  Carrigan AC,  Teal RW,  Good MJ,  McCaskill-Stevens W,  Grubbs SS
J Oncol Pract 2016 Jan;12(1):63-35
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26627979
PMC ID: PMC4976452

A Report of the Women's Health Congress Workshop on The Health of Women of Color: A Critical Intersection at the Corner of Sex/Gender and Race/Ethnicity.

Plank-Bazinet JL,  Kornstein SG,  Clayton JA,  McCaskill-Stevens W,  Wood L,  Cook N,  Tajuddin SM,  Brown GM,  Harris T,  Evans MK,  Begg L,  Brooks CE,  Miller LR,  Mistretta AC,  Cornelison TL
J Womens Health (Larchmt) 2016 Jan;25(1):4-10
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26771559
PMC ID: PMC4741201

Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future.

Sagae S,  Monk BJ,  Pujade-Lauraine E,  Gaffney DK,  Narayan K,  Ryu SY,  McCormack M,  Plante M,  Casado A,  Reuss A,  Chávez-Blanco A,  Kitchener H,  Nam BH,  Jhingran A,  Temkin S,  Mileshkin L,  Berns E,  Scholl S,  Doll C,  Abu-Rustum NR,  Lecuru F,  Small W Jr,  Gynecologic Cancer InterGroup Cervix Cancer brainstorming day
Int J Gynecol Cancer 2016 Jan;26(1):199-207
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26569057
PMC ID: PMC4831060

Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement.

Ligibel JA,  Alfano CM,  Hershman D,  Ballard RM,  Bruinooge SS,  Courneya KS,  Daniels EC,  Demark-Wahnefried W,  Frank ES,  Goodwin PJ,  Irwin ML,  Levit LA,  McCaskill-Stevens W,  Minasian LM,  O'Rourke MA,  Pierce JP,  Stein KD,  Thomson CA,  Hudis CA
J Clin Oncol 2015 Nov 20;33(33):3961-7
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director
PubMed ID: 26324364
PMC ID: not available

Increasing Minority Enrollment Onto Clinical Trials: Practical Strategies and Challenges Emerge From the NRG Oncology Accrual Workshop.

Brooks SE,  Muller CY,  Robinson W,  Walker EM,  Yeager K,  Cook ED,  Friedman S,  Somkin CP,  Brown CL,  McCaskill-Stevens W
J Oncol Pract 2015 Nov;11(6):486-90
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26464496
PMC ID: PMC5706134

My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR).

Holmberg C,  Waters EA,  Whitehouse K,  Daly M,  McCaskill-Stevens W
Med Decis Making 2015 Nov;35(8):1010-22
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26183166
PMC ID: PMC4592416

Gaining control over breast cancer risk: Transforming vulnerability, uncertainty, and the future through clinical trial participation - a qualitative study.

Holmberg C,  Whitehouse K,  Daly M,  McCaskill-Stevens W
Sociol Health Illn 2015 Nov;37(8):1373-87
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26235092
PMC ID: PMC4609249

A cluster-randomized study of clinician-patient shared vs standard reporting of symptomatic adverse events using PRO-CTCAE nested in a multicenter trial of multimodal therapy for rectal cancer (Alliance N1048 PROSPECT)

Dueck Amylou C.,  Mitchell Sandra A.,  Rogak Lauren J.,  Ginos Brenda,  Sargent Daniel J.,  Shi Qian,  Farma Jeffrey M.,  Eng Cathy,  Crane Christopher,  Kennecke Hagen,  O'Mara Ann M.,  Minasian Lori M.,  Schrag Deborah,  Basch Ethan
Qual Life Res 2015 Oct 1;24(1 Suppl):1-2
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director ;  Supportive Care and Symptom Management
PubMed ID: not available
PMC ID: not available

Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers.

Temkin SM,  Seibel NL
Cancer 2015 Oct 1;121(19):3395-402
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26110510
PMC ID: not available

Cooperative Group Trials in the Community Setting.

Lloyd Wade J 3rd,  Petrelli NJ,  McCaskill-Stevens W
Semin Oncol 2015 Oct;42(5):686-92
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26433550
PMC ID: PMC4692715

Casing uncertainty in LCIS recommendations through two patient narratives

Blakeslee Sarah B.,  Parker Patricia A.,  Gunn Christine M.,  Bandos Hanna,  Battaglia Tracy A.,  Bevers Therese B.,  McCaskill-Stevens Worta,  Mueller-Nordhorn Jacqueline,  Holmberg Christine
Eur J Cancer Care 2015 Sep 1;24(Suppl 2):32-32
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: not available
PMC ID: not available

Cancer Care Delivery Research: Building the Evidence Base to Support Practice Change in Community Oncology.

Kent EE,  Mitchell SA,  Castro KM,  DeWalt DA,  Kaluzny AD,  Hautala JA,  Grad O,  Ballard RM,  McCaskill-Stevens WJ,  Kramer BS,  Clauser SB
J Clin Oncol 2015 Aug 20;33(24):2705-11
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director
PubMed ID: 26195715
PMC ID: PMC4559611

Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program.

Dimond EP,  St Germain D,  Nacpil LM,  Zaren HA,  Swanson SM,  Minnick C,  Carrigan A,  Denicoff AM,  Igo KE,  Acoba JD,  Gonzalez MM,  McCaskill-Stevens W
Clin Trials 2015 Jun;12(3):246-56
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 25691600
PMC ID: PMC4420772

Geographic disparities amongst patients with gynecologic malignancies at an urban NCI-designated cancer center.

Temkin SM,  Fleming SA,  Amrane S,  Schluterman N,  Terplan M
Gynecol Oncol 2015 Jun;137(3):497-502
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 25795262
PMC ID: not available

Decision-making in breast cancer risk reduction: Results from a nested qualitative study from NRG Oncology/NSABP protocol DMP-1

Blakeslee Sarah B.,  Parker Patricia A.,  Gunn Christine M.,  Bandos Hanna,  Bevers Therese Bartholomew,  Battaglia Tracy Ann,  Fagerlin Angela,  McCaskill-Stevens Worta J.,  Holmberg Christine
J Clin Oncol 2015 May 20;33(15):Abstract e17569
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: not available
PMC ID: not available

Creating a national collaborative strategy to enhance trial accrual in NCI's National Clinical Trials Network (NCTN) in the era of precision medicine

Denicoff Andrea,  Massett Holly A.,  Mishkin Grace E.,  Bangs Rick,  Berlin Jordan,  Bischoff Miriam B.,  DeSanto Frank,  Duli Anne,  Horvath Laura E.,  Katz Michael S.,  Lambersky Ruth,  Mann Bhupinder Singh,  McCaskill-Stevens Worta J.,  Seibel Nita,  Stine Sharon Hartson,  Williams Wade,  Mooney Margaret M.,  Abrams Jeffrey S.
J Clin Oncol 2015 May 20;33(15):Abstract 6589
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: not available
PMC ID: not available

"Less is more:" The harms of overtreatment in early ovarian cancer.

Temkin SM
Gynecol Oncol 2015 May;137(2):191-2
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 25953509
PMC ID: not available

Generalizability of established prostate cancer risk variants in men of African ancestry.

Han Y,  Signorello LB,  Strom SS,  Kittles RA,  Rybicki BA,  Stanford JL,  Goodman PJ,  Berndt SI,  Carpten J,  Casey G,  Chu L,  Conti DV,  Rand KA,  Diver WR,  Hennis AJ,  John EM,  Kibel AS,  Klein EA,  Kolb S,  Le Marchand L,  Leske MC,  Murphy AB,  Neslund-Dudas C,  Park JY,  Pettaway C,  Rebbeck TR,  Gapstur SM,  Zheng SL,  Wu SY,  Witte JS,  Xu J,  Isaacs W,  Ingles SA,  Hsing A,  PRACTICAL Consortium,  ELLIPSE GAME-ON Consortium,  Easton DF,  Eeles RA,  Schumacher FR,  Chanock S,  Nemesure B,  Blot WJ,  Stram DO,  Henderson BE,  Haiman CA
Int J Cancer 2015 Mar 1;136(5):1210-7
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 25044450
PMC ID: PMC4268262
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

What is cancer nursing research?

O'Mara A
Cancer Nurs 2015 Mar-Apr;38(2):81-2
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 25689041
PMC ID: not available

Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.

Christen WG,  Glynn RJ,  Gaziano JM,  Darke AK,  Crowley JJ,  Goodman PJ,  Lippman SM,  Lad TE,  Bearden JD,  Goodman GE,  Minasian LM,  Thompson IM Jr,  Blanke CD,  Klein EA
JAMA Ophthalmol 2015 Jan;133(1):17-24
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 25232809
PMC ID: PMC4395006
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Retention of black and white participants in the selenium and vitamin E cancer prevention trial (SWOG-coordinated intergroup study S0000).

Arnold KB,  Hermos JA,  Anderson KB,  Minasian L,  Tangen CM,  Probstfield JF,  Cook ED
Cancer Epidemiol Biomarkers Prev 2014 Dec;23(12):2895-905
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 25242051
PMC ID: PMC4257858
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Organizational and physician factors associated with patient enrollment in cancer clinical trials.

Jacobs SR,  Weiner BJ,  Reeve BB,  Weinberger M,  Minasian LM,  Good MJ
Clin Trials 2014 Oct;11(5):565-75
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 24902923
PMC ID: PMC4156916

Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?

Liang Y,  Ketchum NS,  Goodman PJ,  Klein EA,  Thompson IM Jr
J Urol 2014 Oct;192(4):1094-9
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 24747090
PMC ID: PMC4194238
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Albanes D,  Till C,  Klein EA,  Goodman PJ,  Mondul AM,  Weinstein SJ,  Taylor PR,  Parnes HL,  Gaziano JM,  Song X,  Fleshner NE,  Brown PH,  Meyskens FL Jr,  Thompson IM
Cancer Prev Res (Phila) 2014 Sep;7(9):886-95
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 24961880
PMC ID: PMC4408535
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Basch E,  Reeve BB,  Mitchell SA,  Clauser SB,  Minasian LM,  Dueck AC,  Mendoza TR,  Hay J,  Atkinson TM,  Abernethy AP,  Bruner DW,  Cleeland CS,  Sloan JA,  Chilukuri R,  Baumgartner P,  Denicoff A,  St Germain D,  O'Mara AM,  Chen A,  Kelaghan J,  Bennett AV,  Sit L,  Rogak L,  Barz A,  Paul DB,  Schrag D
J Natl Cancer Inst 2014 Sep;106(9)
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director
PubMed ID: 25265940
PMC ID: PMC4200059

Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.

Crowe FL,  Appleby PN,  Travis RC,  Barnett M,  Brasky TM,  Bueno-de-Mesquita HB,  Chajes V,  Chavarro JE,  Chirlaque MD,  English DR,  Gibson RA,  Giles GG,  Goodman GE,  Henning SM,  Kaaks R,  King IB,  Kolonel LN,  Kristal AR,  Neuhouser ML,  Park SY,  Severi G,  Siddiq A,  Stampfer MJ,  Stattin P,  Tangen CM,  Tjønneland A,  Trichopoulos D,  Tumino R,  Wilkens LR,  Key TJ,  Allen NE,  Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group
J Natl Cancer Inst 2014 Sep;106(9)
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 25210201
PMC ID: PMC4188122
Clinical Trials: Prostate Cancer Prevention Trial (PCPT) ;  Selenium and Vitamin E Cancer Prevention Trial (SELECT)

A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Martinez EE,  Darke AK,  Tangen CM,  Goodman PJ,  Fowke JH,  Klein EA,  Abdulkadir SA
Cancer Prev Res (Phila) 2014 Sep;7(9):950-7
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 24894197
PMC ID: PMC4154984
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities.

Shelburne N,  Adhikari B,  Brell J,  Davis M,  Desvigne-Nickens P,  Freedman A,  Minasian L,  Force T,  Remick SC
J Natl Cancer Inst 2014 Sep;106(9)
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsSupportive Care and Symptom Management
PubMed ID: 25210198
PMC ID: PMC4176042

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.

Wolpin BM,  Rizzato C,  Kraft P,  Kooperberg C,  Petersen GM,  Wang Z,  Arslan AA,  Beane-Freeman L,  Bracci PM,  Buring J,  Canzian F,  Duell EJ,  Gallinger S,  Giles GG,  Goodman GE,  Goodman PJ,  Jacobs EJ,  Kamineni A,  Klein AP,  Kolonel LN,  Kulke MH,  Li D,  Malats N,  Olson SH,  Risch HA,  Sesso HD,  Visvanathan K,  White E,  Zheng W,  Abnet CC,  Albanes D,  Andreotti G,  Austin MA,  Barfield R,  Basso D,  Berndt SI,  Boutron-Ruault MC,  Brotzman M,  Büchler MW,  Bueno-de-Mesquita HB,  Bugert P,  Burdette L,  Campa D,  Caporaso NE,  Capurso G,  Chung C,  Cotterchio M,  Costello E,  Elena J,  Funel N,  Gaziano JM,  Giese NA,  Giovannucci EL,  Goggins M,  Gorman MJ,  Gross M,  Haiman CA,  Hassan M,  Helzlsouer KJ,  Henderson BE,  Holly EA,  Hu N,  Hunter DJ,  Innocenti F,  Jenab M,  Kaaks R,  Key TJ,  Khaw KT,  Klein EA,  Kogevinas M,  Krogh V,  Kupcinskas J,  Kurtz RC,  LaCroix A,  Landi MT,  Landi S,  Le Marchand L,  Mambrini A,  Mannisto S,  Milne RL,  Nakamura Y,  Oberg AL,  Owzar K,  Patel AV,  Peeters PH,  Peters U,  Pezzilli R,  Piepoli A,  Porta M,  Real FX,  Riboli E,  Rothman N,  Scarpa A,  Shu XO,  Silverman DT,  Soucek P,  Sund M,  Talar-Wojnarowska R,  Taylor PR,  Theodoropoulos GE,  Thornquist M,  Tjønneland A,  Tobias GS,  Trichopoulos D,  Vodicka P,  Wactawski-Wende J,  Wentzensen N,  Wu C,  Yu H,  Yu K,  Zeleniuch-Jacquotte A,  Hoover R,  Hartge P,  Fuchs C,  Chanock SJ,  Stolzenberg-Solomon RS,  Amundadottir LT
Nat Genet 2014 Sep;46(9):994-1000
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 25086665
PMC ID: PMC4191666
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Clinical research education: perspectives of nurses, employers, and educators.

Galassi AL,  Grady MA,  O'Mara AM,  Ness EA,  Parreco LK,  Belcher AE,  Hastings CE
J Nurs Educ 2014 Aug;53(8):466-72
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 25050563
PMC ID: not available

Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217).

Gritz ER,  Arnold KB,  Moinpour CM,  Burton-Chase AM,  Tangen CM,  Probstfield JF,  See WA,  Lieber MM,  Caggiano V,  Moody-Thomas S,  Szczepanek C,  Ryan A,  Carlin S,  Hill S,  Goodman PJ,  Padberg RM,  Minasian LM,  Meyskens FL,  Thompson IM Jr
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1638-48
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director ;  Community Clinical Oncology Program ;  Prostate and Urologic Cancer
PubMed ID: 25028457
PMC ID: PMC4119542
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.

Kristal AR,  Till C,  Song X,  Tangen CM,  Goodman PJ,  Neuhauser ML,  Schenk JM,  Thompson IM,  Meyskens FL Jr,  Goodman GE,  Minasian LM,  Parnes HL,  Klein EA
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1494-504
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director ;  Prostate and Urologic Cancer ;  Community Clinical Oncology Program
PubMed ID: 24732629
PMC ID: PMC4119495
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Statin drug use is not associated with prostate cancer risk in men who are regularly screened.

Platz EA,  Tangen CM,  Goodman PJ,  Till C,  Parnes HL,  Figg WD,  Albanes D,  Neuhouser ML,  Klein EA,  Lucia MS,  Thompson IM Jr,  Kristal AR
J Urol 2014 Aug;192(2):379-84
Major Program(s) or Research Group(s): Prostate and Urologic Cancer ;  Community Clinical Oncology Program ;  Community Oncology and Prevention Trials
PubMed ID: 24518774
PMC ID: PMC4104140
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.

Schenk JM,  Till CA,  Tangen CM,  Goodman PJ,  Song X,  Torkko KC,  Kristal AR,  Peters U,  Neuhouser ML
Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1484-93
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 25085836
PMC ID: PMC4120235
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial.

Figg WD,  Chau CH,  Price DK,  Till C,  Goodman PJ,  Cho Y,  Varella-Garcia M,  Reichardt JK,  Tangen CM,  Leach RJ,  van Bokhoven A,  Thompson IM,  Lucia MS
Urology 2014 Jul;84(1):127-31
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 24824408
PMC ID: PMC4077907
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.

Reeve BB,  Mitchell SA,  Dueck AC,  Basch E,  Cella D,  Reilly CM,  Minasian LM,  Denicoff AM,  O'Mara AM,  Fisch MJ,  Chauhan C,  Aaronson NK,  Coens C,  Bruner DW
J Natl Cancer Inst 2014 Jul;106(7)
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director
PubMed ID: 25006191
PMC ID: PMC4110472

Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.

Ankerst DP,  Hoefler J,  Bock S,  Goodman PJ,  Vickers A,  Hernandez J,  Sokoll LJ,  Sanda MG,  Wei JT,  Leach RJ,  Thompson IM
Urology 2014 Jun;83(6):1362-7
Major Program(s) or Research Group(s): Community Clinical Oncology Program ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
PubMed ID: 24862395
PMC ID: PMC4035700
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)